Only 29 percent of children in that group have received the two-shot regimen of the Pfizer-BioNTech vaccine, according to the CDC. He said he supported authorization — as long as a third Moderna dose is on the way. AdvertisementTuesday’s action, however, was focused on use of the Moderna vaccine for children 6 through 17. AdvertisementTesting of the pediatric coronavirus vaccines is not designed primarily to measure directly whether the shots prevented symptomatic illness. There were no confirmed cases of myocarditis or pericarditis in the Moderna trials for infants, children and adolescents — but the trials might have been too small to pick it up.

Source: Washington Post June 15, 2022 11:37 UTC